• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在使用伊匹单抗和纳武单抗治疗转移性肾细胞癌期间出现的干燥综合征。

Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma.

作者信息

Segawa Takuya, Motoshima Takanobu, Yatsuda Junji, Kurahashi Ryoma, Fukushima Yumi, Murakami Yoji, Yamaguchi Takahiro, Sugiyama Yutaka, Yoshida Ryoji, Nakayama Hideki, Kamba Tomomi

机构信息

Department of Urology Kumamoto University Kumamoto Japan.

Department of Oral and Maxillofacial Surgery Kumamoto University Kumamoto Japan.

出版信息

IJU Case Rep. 2023 Jan 6;6(2):147-149. doi: 10.1002/iju5.12573. eCollection 2023 Mar.

DOI:10.1002/iju5.12573
PMID:36874997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9978085/
Abstract

INTRODUCTION

Dry mouth is the main symptom of sicca syndrome, which rarely occurs as an immune-related adverse event. Here we report a case of sicca syndrome caused by immune checkpoint inhibitor treatment.

CASE PRESENTATION

A 70-year-old man was diagnosed with left renal cell carcinoma after radical left nephrectomy. Nine years later, computed tomography revealed a metastatic nodule in the upper left lung lobe. Subsequently, ipilimumab and nivolumab were administered for recurrent disease. After 13 weeks of treatment, xerostomia and dysgeusia were noted. Salivary gland biopsy revealed lymphocyte and plasma cell infiltration in the salivary glands. Sicca syndrome was diagnosed and pilocarpine hydrochloride was prescribed without corticosteroids, with continuation of immune checkpoint inhibitor therapy. The symptoms alleviated after 36 weeks of treatment, with shrinkage of the metastatic lesions.

CONCLUSION

We experienced sicca syndrome caused by immune checkpoint inhibitors. Sicca syndrome improved without steroids and the immunotherapy could be continued.

摘要

引言

口干是干燥综合征的主要症状,很少作为免疫相关不良事件出现。在此我们报告一例由免疫检查点抑制剂治疗引起的干燥综合征病例。

病例介绍

一名70岁男性在接受根治性左肾切除术后被诊断为左肾细胞癌。九年后,计算机断层扫描显示左上肺叶有一个转移结节。随后,给予伊匹木单抗和纳武单抗治疗复发性疾病。治疗13周后,出现口干和味觉障碍。唾液腺活检显示唾液腺中有淋巴细胞和浆细胞浸润。诊断为干燥综合征,在未使用皮质类固醇的情况下开具了盐酸毛果芸香碱,并继续进行免疫检查点抑制剂治疗。治疗36周后症状缓解,转移病灶缩小。

结论

我们遇到了由免疫检查点抑制剂引起的干燥综合征。干燥综合征在未使用类固醇的情况下得到改善,免疫治疗可以继续。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/beefd40372bd/IJU5-6-147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/5ce6ba7eec98/IJU5-6-147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/00326b6b386f/IJU5-6-147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/beefd40372bd/IJU5-6-147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/5ce6ba7eec98/IJU5-6-147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/00326b6b386f/IJU5-6-147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69b/9978085/beefd40372bd/IJU5-6-147-g002.jpg

相似文献

1
Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma.在使用伊匹单抗和纳武单抗治疗转移性肾细胞癌期间出现的干燥综合征。
IJU Case Rep. 2023 Jan 6;6(2):147-149. doi: 10.1002/iju5.12573. eCollection 2023 Mar.
2
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.干燥综合征与免疫检查点抑制剂治疗相关。
Oncologist. 2019 Sep;24(9):1259-1269. doi: 10.1634/theoncologist.2018-0823. Epub 2019 Apr 17.
3
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.免疫检查点抑制剂治疗转移性肾细胞癌后发生心肌炎的病例报告:免疫相关不良事件。
J Med Case Rep. 2021 Oct 15;15(1):508. doi: 10.1186/s13256-021-03097-6.
4
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.转移性肾细胞癌患者停用免疫检查点抑制剂后疾病持久控制且并发难治性大疱性类天疱疮:一例报告。
Front Immunol. 2022 Sep 16;13:984132. doi: 10.3389/fimmu.2022.984132. eCollection 2022.
5
A case of sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma.1例转移性肾细胞癌中与免疫检查点抑制剂相关的结节病样反应
IJU Case Rep. 2021 Sep 24;5(1):15-18. doi: 10.1002/iju5.12372. eCollection 2022 Jan.
6
Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report.免疫相关性间质性肺炎后再次使用纳武利尤单抗治疗转移性肾细胞癌:病例报告。
Am J Case Rep. 2021 Aug 6;22:e932924. doi: 10.12659/AJCR.932924.
7
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.纳武单抗和伊匹单抗诱发的炎性关节炎和干燥综合征。
Ann Rheum Dis. 2017 Jan;76(1):43-50. doi: 10.1136/annrheumdis-2016-209595. Epub 2016 Jun 15.
8
Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.干燥综合征作为纳武利尤单抗治疗胃癌的免疫相关不良事件。
Intern Med. 2020 Oct 15;59(20):2499-2504. doi: 10.2169/internalmedicine.4701-20. Epub 2020 Jun 23.
9
Hyperprogressive Disease In a Metastatic Renal Cell Carcinoma Patient After Receiving Immune Checkpoint Inhibitors: A Case Report.免疫检查点抑制剂治疗后转移性肾细胞癌患者出现的超进展性疾病:一例报告
Cureus. 2022 Oct 11;14(10):e30194. doi: 10.7759/cureus.30194. eCollection 2022 Oct.
10
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma.在接受纳武单抗治疗转移性肾细胞癌后获得持久完全缓解的患者中观察到白癜风不良事件。
Front Oncol. 2019 Oct 9;9:1033. doi: 10.3389/fonc.2019.01033. eCollection 2019.

引用本文的文献

1
CRISPR-Cas9 editing of variants in salivary gland epithelial cells to study Sjögren's disease pathogenesis.对唾液腺上皮细胞中的变异体进行CRISPR-Cas9编辑以研究干燥综合征的发病机制。
Front Genome Ed. 2025 Jul 23;7:1625393. doi: 10.3389/fgeed.2025.1625393. eCollection 2025.

本文引用的文献

1
Xerostomia: an immunotherapy-related adverse effect in cancer patients.口干症:癌症患者的一种免疫治疗相关不良反应。
Support Care Cancer. 2022 Feb;30(2):1681-1687. doi: 10.1007/s00520-021-06535-9. Epub 2021 Sep 25.
2
Sicca syndrome associated with immune checkpoint inhibitor therapy.与免疫检查点抑制剂治疗相关的干燥综合征
Oral Dis. 2022 Nov;28(8):2083-2092. doi: 10.1111/odi.14000. Epub 2021 Aug 17.
3
Checkpoint inhibition-induced sicca: a type II interferonopathy?免疫检查点抑制相关干燥症:Ⅱ型干扰素病?
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):253-260. Epub 2020 Sep 22.
4
Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor.服用抗PD-L1免疫检查点抑制剂患者腮腺中缺乏传统腺泡细胞
Front Oncol. 2020 Apr 2;10:420. doi: 10.3389/fonc.2020.00420. eCollection 2020.
5
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.免疫检查点抑制剂治疗导致的干燥综合征:最佳治疗方案仍有待确定。
Oncologist. 2020 Feb;25(2):e391-e395. doi: 10.1634/theoncologist.2019-0467. Epub 2019 Nov 6.
6
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).由 PD-1/PD-L1 检查点抑制剂引发的干燥综合征/舍格伦综合征。来自国际免疫癌症登记处(ICIR)的数据。
Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):114-122. Epub 2019 Aug 28.
7
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.干燥综合征与免疫检查点抑制剂治疗相关。
Oncologist. 2019 Sep;24(9):1259-1269. doi: 10.1634/theoncologist.2018-0823. Epub 2019 Apr 17.
8
Association of good oncological response to therapy with the development of rheumatic immune-related adverse events following PD-1 inhibitor therapy.PD-1抑制剂治疗后良好的肿瘤治疗反应与风湿免疫相关不良事件发生之间的关联。
Int J Rheum Dis. 2019 Feb;22(2):297-302. doi: 10.1111/1756-185X.13444. Epub 2018 Nov 22.
9
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.免疫相关不良事件对纳武利尤单抗治疗的晚期非小细胞肺癌患者生存的影响:多机构分析的长期结果。
J Cancer Res Clin Oncol. 2019 Feb;145(2):479-485. doi: 10.1007/s00432-018-2805-3. Epub 2018 Dec 1.
10
Salivary secretion in health and disease.健康与疾病状态下的唾液分泌
J Oral Rehabil. 2018 Sep;45(9):730-746. doi: 10.1111/joor.12664. Epub 2018 Jun 25.